Dual Effect of the Gene Variant in the Molecular Pathogenesis of Obesity
Overview
Authors
Affiliations
Obesity is as a global health problem due to its interaction with complex chronic disorders such as cardiovascular disorders, type 2 diabetes mellitus (T2DM) and cancer. Despite the fact that pathogenesis of obesity is not yet clearly understood, it is associated with a combination of psychological, environmental and various genetic factors. Here, employing a case-control design, we aimed to examine the effects of the c.152C>T (p.Arg51Gln) (rs34911341) and c.214G>T (p.Leu72Met) (rs696217) markers on susceptibility to obesity in a Turkish-Cypriot population, as well as to evaluate whether these markers affect biochemical parameters and show their putative functional consequences. This study involved 211 Turkish-Cypriot subjects (106 obese and 95 non obese). Genotyping for the gene polymorphisms was performed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. Our results indicate that the Leu72Met polymorphism was found to be significantly higher in obese patients, with respect to genotypic ( = 0.0012) and allelic ( = 0.0005) frequencies. Strikingly, the rs696217 GT genotype (heterozygous) had significantly lower serum high-density lipoprotein cholesterol (HDL-C) ( = 0.015) than GG (wild type) genotypes. Overall, Leu72Met susceptibility variant may be considered as risk and crucial marker for both obesity and cholesterol metabolism in the community of Turkish-Cypriots. Thus, the dual effect of the gene Leu72Met variant may be used for clinical diagnosis.
Polygenic Score Approach to Predicting Risk of Metabolic Syndrome.
Timasheva Y, Kochetova O, Balkhiyarova Z, Korytina G, Prokopenko I, Nouwen A Genes (Basel). 2025; 16(1).
PMID: 39858569 PMC: 11764775. DOI: 10.3390/genes16010022.
Genes Involved in Susceptibility to Obesity and Emotional Eating Behavior in a Romanian Population.
Vranceanu M, Filip L, Heghes S, de Lorenzo D, Cozma-Petrut A, Ghitea T Nutrients. 2024; 16(16).
PMID: 39203789 PMC: 11357152. DOI: 10.3390/nu16162652.
Celik N, Sezer A, Genel N, Savas-Erdeve S, Karaman I, Cetinkaya S Front Endocrinol (Lausanne). 2024; 15:1426916.
PMID: 39036055 PMC: 11257912. DOI: 10.3389/fendo.2024.1426916.